Institutional Ownership
Halozyme Therapeutics Inc
CUSIP 40637H109COMHALOQ1 2026
13D / 13G Filings
31
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
14.2%
Max % of class reported
Institutional Holders
625
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
31 filings · latest Jul 17, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 10.2% | 12.61M | SEC |
| 2 | May 13, 2025 | State Street Corporation | 13G | 4.9% | 6.05M | SEC |
| 3 | Apr 28, 2025 | Blackrock, Inc. | 13G/A | 13.1% | 16.14M | SEC |
| 4 | Nov 12, 2024 | Artisan Partners Limited Partnership | 13G/A | 2.5% | 3.13M | SEC |
| 5 | Oct 17, 2024 | State Street Corp | 13G | 5.2% | 6.64M | SEC |
| 6 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 10.0% | 13.26M | SEC |
| 7 | Feb 12, 2024 | Artisan Partners Limited Partnership | 13G/A | 5.1% | 6.69M | SEC |
| 8 | Feb 1, 2024 | Invesco Ltd. | 13G/A | 2.1% | 2.82M | SEC |
| 9 | Jan 23, 2024 | Blackrock Inc. | 13G/A | 14.1% | 18.63M | SEC |
| 10 | Jun 9, 2023 | Vanguard Group Inc | 13G/A | 10.3% | 13.53M | SEC |
21 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Halozyme Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 13.27M | $857.32M |
| 2 | State Street Corp | 4.94M | $319.13M |
| 3 | Invesco Ltd. | 4.01M | $259.33M |
| 4 | Bank Of America Corp /De/ | 2.91M | $188.27M |
| 5 | Boston Partners | 2.68M | $173.43M |
| 6 | Morgan Stanley | 2.56M | $165.60M |
| 7 | William Blair Investment Management, LLC | 2.53M | $163.25M |
| 8 | Geode Capital Management, LLC | 2.51M | $161.98M |
| 9 | Snyder Capital Management L P | 2.32M | $150.14M |
| 10 | Dimensional Fund Advisors LP | 2.08M | $134.40M |